DRUG · Mapped RxNorm record
Tocilizumab
Normalized identity: tocilizumabView linked drug · Find medicine records ·
Find other trials using this name
Clinical trial
A Study of Tocilizumab in Combination With DMARDs in Patients With Moderate to Severe Rheumatoid Arthritis
NCT00531817
Drugs and interventions used in this trial
3 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
DRUG · Unmapped registry intervention
Placebo
Find medicine records ·
Find other trials using this name
DRUG · Unmapped registry intervention
Permitted DMARDs
Find medicine records ·
Find other trials using this name
No matching interventions in this trial.
Study at a glance
Registry-backedA Study of Tocilizumab in Combination With DMARDs in Patients With Moderate to Severe Rheumatoid Arthritis
Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE3
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Interventions
Sponsors & collaborators
Hoffmann-La Rochelead sponsor
Mapped research locations
HoustonTexas, United States4San AntonioTexas, United States3BirminghamAlabama, United States3New YorkNew York, United States2PhiladelphiaPennsylvania, United States2SeattleWashington, United States2Oklahoma CityOklahoma, United States2Las VegasNevada, United States2CharlotteNorth Carolina, United States2ScottsdaleArizona, United States2Baton RougeLouisiana, United States2WorcesterMassachusetts, United States2
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT00531817 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.